Data / Form D filings / Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc.: Form D filings
Anebulo Pharmaceuticals, Inc., a pharmaceuticals company in Lakeway, TX, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on December 31, 2024, reports $15 million sold of a $15 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1017 RANCH ROAD 620 SOUTH, SUITE 107, Lakeway, TX, 78734
- Phone
- (512) 598-0931
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1815974
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | New notice | $15,000,000 | $15,000,000 | 1 | Dec 22, 2024 | sec.gov | |
| Oct 11, 2022 | New notice | $16,192,248 | $6,646,748 | $9,545,500 | 5 | Sep 28, 2022 | sec.gov |
| Jun 25, 2020 | New notice | $5,250,000 | $3,000,000 | $2,250,000 | 1 | Jun 18, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Cunningham | Executive Officer, Director | |
| Daniel George | Executive Officer | |
| Jason R. Aryeh | Director | |
| Aron R. English | Director | |
| Kenneth R. Lin | Director | |
| Joseph F. Lawler | Director | |
| Areta R. Kupchyk | Director | |
| Bimal R. Shah | Director | |
| Nathaniel R. Calloway | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Anebulo Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.